Cite

HARVARD Citation

    Tucker, H. et al. (n.d.). NICE guidance on olaparib for maintenance treatment of patients with relapsed, platinum-sensitive, BRCA mutation-positive ovarian cancer. Lancet oncology. 17 (3), pp. 277-278. [Online]. 
  
Back to record